2021 yil oktyabr: Kabozantinib (Cabometyx, Exelixis, Inc.) Oziq-ovqat va farmatsevtika idorasi tomonidan mahalliy rivojlangan yoki metastatik tabaqalashtirilgan qalqonsimon bezga ega bo'lgan 12 yosh va undan katta kattalar va pediatrik bemorlar uchun tasdiqlangan.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..